Mirum Pharmaceuticals, Inc. MIRM Non-cash lease expense
Non-cash lease expense at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept mirm:NonCashLeaseExpense.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s non-cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s non-cash lease expense?
- Mirum Pharmaceuticals, Inc. (MIRM) reported non-cash lease expense of $550K in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s non-cash lease expense changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s non-cash lease expense increased by 41.0% year-over-year, from $390K to $550K.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s non-cash lease expense?
- Over 2 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s non-cash lease expense has grown at a 113.4% compound annual growth rate (CAGR), from $380K to $1.73M.
- What does non-cash lease expense mean?
- This represents the portion of lease costs recognized as an expense that does not involve a direct cash outflow during the period. It is primarily associated with the amortization of right-of-use assets under accounting standards for operating leases. It is a key adjustment to reconcile net income to operating cash flow.